During his tenure as president of ASAP, LLC, Mohsen Grayeli has spearheaded numerous government property renovations, including the Family Court of the District of Columbia Superior Court. In addition to his professional work, Mohsen Grayeli maintains an active role in supporting various charitable organizations, including the American Cancer Society.
A recent study by the American Cancer Society shows that the rate of anal cancer is increasing across the globe, with the rate seeing a jump in both male and female populations in 13 different countries. According to study researchers, the human papillomavirus (HPV) vaccination could serve as a helpful tool in the fight against the disease.
A rare form of the disease, anal cancer only affected about 27,000 people throughout the world in 2008. However, according to researchers that number is on the rise, especially in places such as the Americas, Northern and Western Europe, and Australia.
The leading researcher of this study, Farhad Islami, MD, PhD, surveyed data gathered by the Agency for Research on Cancer’s Cancer Incidence in Five Continents to determine the anal cancer rate across 18 different countries, with 13 showing a rate increase in a particular type of anal cancer known as anal squamous cell carcinoma (ASCC).
Islami says that his research indicates that ASCC rates could be increasing in these population due to a higher-than-usual rate of infection with HPV, which is typically found to be present in those diagnosed with ASCC. While the vaccine can protect an individual against HPV itself, researchers say that more study needs to be done to see if the vaccine has any direct preventative benefit against anal cancer.